Search results for: 'parc paas analysis for laboratory develop'
- Related search terms
- analysis of the north american radiology image and information management systemnorth american radiology pacs and (ris(ris pacs) market
- analysis of the drug delivery devices market forecast to 2023
- analysis-of-top-30-features-of-mass-market-and-luxury-oems-in-northt-america
- analysis-of-the-ethiopian-pharmaceutical-market.html®ions=234
- paas 01 00 00 00
-
23 Dec 2020  |  North America  |  Market Research
I-O Therapy Combinations Spurring Growth of the Global Immuno-oncology Market
Upcoming Product Launches in Adoptive Cell Therapy Segment Hold Future Growth Potential
This study explores the global immuno-oncology (I-O) markets evolution from 2020 to 2025. An extensive analysis is provided on the growth opportunities envisioned by Frost & Sullivan to help stakeholders leverage their momentum and disrupt the market by offering best-in-class solutions. The study considers oncology agents for which the immune syst...
$4,950.00
Special Price $3,712.50 save 25 %
-
26 Oct 2022  |  North America  |  Frost Radar
Frost Radar™: North American UCaaS Market, 2022
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
As the North American unified communications-as-a-service (UCaaS) market matures and competition intensifies, it is becoming increasingly important for market participants to accelerate innovation and develop sustainable growth strategies. This market analysis provides a perspective on key market trends as well as an assessment of 30 growth and inn...
$4,950.00
Special Price $3,712.50 save 25 %
-
24 Oct 2018  |  North America  |  Market Research
Growth Opportunities in the Global Cell Therapy Market, Forecast to 2025
A Robust Product Pipeline Creating Opportunities for Ground-breaking Combination Therapies is Set to Revolutionize the Global Cell Therapy Market
The global pharmaceuticals industry is continuously evolving to meet the requirements of a changing disease landscape. With the increasing prevalence of chronic infectious diseases and cancer, market needs are shifting from traditional small molecules to novel large molecule therapies, with cell therapies dominating the space. This study presents a...
$4,950.00
Special Price $3,712.50 save 25 %
-
24 Sep 2026  |  North America  |  Market Research
Military Aviation Maintenance, Repair, and Overhaul Industry, US, 2025–2030
Higher Operational Tempo Drives Transformational Growth by Increasing Investments in Advanced Technologies
This research service provides a comprehensive overview of the US military aviation maintenance, repair, and overhaul (MRO) industry. The study segments the industry into six platform categories: 1. Fighter, Attack, & Bomber 2. Rotorcraft 3. Transport & Tanker 4. Training & Utility 5. Intelligence, Surveillance, and Reconnaissance (ISR) & Special M...
$4,950.00 -
15 Jun 2022  |  North America  |  Market Research
US Automotive In-vehicle Navigation Growth Opportunities
Augmented Reality, Sensors, Connected Data, and AI Set to Transform Navigation Services for Users and Businesses
The US automotive in-vehicle navigation market is converging. Numerous technological developments, such as cloud computing and AI/ML capabilities, have created numerous new use cases. These opportunities include the integration of augmented reality in head-up display (AR HUD), HD mapping and sensor analysis for ADAS, and personalized services to el...
$4,950.00
Special Price $3,712.50 save 25 %
-
17 Oct 2022  |  North America  |  Market Research
Joint All Domain Command and Control (JADC2) Growth Opportunities
Accelerating Research and Experimentation and Additional Spending will Ensure Transformational Growth
This Frost & Sullivan research service focuses on US Department of Defense (DoD) Joint All-Domain Command and Control (JADC2) program that seeks to improve combat networks at all levels. The study includes representative programs and example contracts for research, development, test, and evaluation; procurement; operations and maintenance; and othe...
$2,450.00
Special Price $1,837.50 save 25 %
-
08 Jun 2022  |  North America  |  Market Research
Growth Opportunities in Sterile Injectable Outsourcing
Biologics Drive the Future Growth Potential of Sterile Injectable Outsourcing
Injectables constitute one of the fastest growing segments in the pharmaceuticals space. Many drugs, including biologics, are going off patent in next 3 or 4 years, which will lead to an increase in the demand for generics and biosimilar injectables. The increase in onshoring and nearshoring of biopharmaceutical products for COVID-19 and next-gen...
$2,450.00
Special Price $1,837.50 save 25 %
-
22 Feb 2022  |  North America  |  Market Research
United States Liquid Biopsy Growth Opportunities
Non-invasive Liquid Biopsy Technology Shapes the Precision Diagnostics Landscape
Healthcare is rapidly becoming patient-centric, focusing on outcomes and value. This offers clinical diagnostics players opportunities to advance their instrument, assay, and informatics capabilities to address unmet clinical needs and increase the precision diagnostics portfolio. Advances in next-generation sequencing-based companion diagnosti...
$4,950.00
Special Price $3,712.50 save 25 %
-
03 Dec 2020  |  North America  |  Market Research
Environmental Credits Powering the Rise of Zero-emission Vehicles, 2020
EV Credits Hold Future Growth Potential, and Pure-play EV OEMs Stand to Benefit the Most
State and federal governments in various countries offer OEMs credit points for developing emission reduction technologies that meet emission standards and promote ZEV vehicles. GHG credit and ZEV credit policies are framed in such a way that both can be used to compensate deficits in a credit policy.--BEGIN PROMO--Research Scope The study aims to...
$4,950.00
Special Price $3,712.50 save 25 %
-
23 Aug 2010  |  North America  |  Market Research
Vital Signs - Biomarkers for Improved and Accelerated Sepsis Treatment: Enabling Clinicians to Definitively Diagnose the Disease, Identify the Causative Agent, and Determine the Appropriate Type and Dosage of Antibiotic
This issue of Vital Signs, released on August 23, 2010, provides a strategic analysis of trends in biomarkers for improved and accelerated sepsis treatment. Additionally, a company spotlight is provided for BRAHMS, a global biotechnology company committed to improving healthcare through the discovery and development of novel and innovative bio...
$1,500.00
Special Price $1,125.00 save 25 %